NASDAQ · SNY
Sanofi financials
$40.74−1.07%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 | FY17 Dec 31 | FY16 Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $54.81B | $46.08B | $46.01B | $43.51B | $44.55B | $45.51B | $42.68B | $41.88B | $40.88B | $37.14B |
| Gross profit | $39.50B | $32.34B | $32.05B | $30.76B | $30.61B | $30.70B | $29.09B | $28.46B | $27.78B | $25.69B |
| Gross margin | 72.1% | 70.2% | 69.7% | 70.7% | 68.7% | 67.5% | 68.2% | 67.9% | 67.9% | 69.2% |
| Operating income | $7.44B | $7.55B | $7.69B | $10.90B | $9.24B | $17.19B | $2.20B | $4.33B | $6.53B | $6.39B |
| Net income | $9.17B | $5.79B | $5.97B | $8.98B | $7.08B | $14.97B | $3.12B | $5.05B | $9.50B | $5.04B |
| Net margin | 16.7% | 12.6% | 13.0% | 20.6% | 15.9% | 32.9% | 7.3% | 12.1% | 23.2% | 13.6% |
| Diluted EPS | $7.47 | $4.61 | $4.75 | $7.14 | $5.63 | $11.89 | $2.48 | $4.03 | $7.49 | $3.89 |
| EBITDA | $18.37B | $13.48B | $14.94B | $15.08B | $14.21B | $23.24B | $15.97B | $11.94B | $11.84B | $11.07B |
| Operating cash flow | $12.61B | $9.45B | $11.34B | $11.29B | $11.97B | $9.03B | $8.75B | $6.51B | $8.33B | $8.76B |
| Free cash flow | $8.46B | $6.12B | $8.13B | $9.04B | $9.64B | $6.50B | $6.72B | $4.19B | $6.12B | $6.53B |
| Diluted shares | 1,225.6M | 1,256.1M | 1,256.4M | 1,256.9M | 1,257.9M | 1,260.1M | 1,257.1M | 1,255.2M | 1,266.8M | 1,296.0M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $8.98B | $7.74B | $9.63B | $13.66B | $11.48B | $16.95B |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $21.81B | $16.65B | $18.12B | $20.41B | $35.85B | $27.42B |
| Total assets | $148.78B | $138.19B | $139.80B | $135.93B | $136.73B | $139.34B |
| Total liabilities | $64.64B | $57.17B | $57.61B | $55.32B | $58.23B | $62.31B |
| Shareholders' equity | $84.14B | $81.02B | $82.19B | $80.61B | $78.50B | $77.03B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology